ÂÜÀòÂÒÂ×

Thomas Meier, Dr. is an experienced professional in the life sciences and pharmaceuticals sectors, currently serving as a Managing Partner at Viopas Venture Consulting GmbH since June 2020. In addition to this role, Thomas Meier holds various board positions, including Board Member at Onconetix Inc. and Visgenx, Inc., Partner at Board Advisors Deutschland AG, and Co-Founder and Chairman of the Board at SEAL Therapeutics AG. Notably, Thomas Meier has been the Chairman of the Board and Chief Executive Officer of Santhera Pharmaceuticals since July 2004, having founded the company. Education includes a Doctor of Philosophy in Zoology/Animal Biology from the University of Basel and extensive postdoctoral experience in neurobiology and neurosciences across multiple prestigious institutions.